Behavioral inhibition is the process in which a person delays or stops engaging in an action or behavior because of the fear of negative consequences. This can include activities such as talking, making eye contact, or even taking a risk. It is related to anxiety in that it often occurs in situations where a person feels anxious or intimidated. Behavioral inhibition can manifest itself in a number of different ways. It can manifest as avoidance or procrastination, in which people avoid a task or situation out of fear. It can also manifest as shyness, where people do not feel comfortable engaging in conversation or interacting socially. Finally, it can manifest as passive aggression, in which people do not openly show their negative feelings or behaviors, but instead act out in passive ways. Behavioral inhibition can have significant consequences on a person's life. Studies have shown that it can lead to decreased academic performance, symptoms of depression, anxiety, and anger, and interpersonal difficulties. In extreme cases, it can even lead to social isolation and withdrawal from activities. Fortunately, there are treatments available to deal with behavioral inhibition. These can range from cognitive-behavioral therapy to medication, and may involve a variety of techniques such as relaxation techniques, role-playing, and breathing exercises. Additionally, support groups can provide a place for people to discuss their experiences in an environment of acceptance and understanding. Overall, behavioral inhibition can be a major source of distress and difficulty for both individuals and those around them. However, with proper intervention, it can be managed and successfully treated, resulting in improved psychological, social, and academic functioning.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom